{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:23:24Z","timestamp":1793525004435,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>High body mass index (BMI) is a major modifiable risk factor for the development and progression of chronic kidney disease (CKD) through established mechanisms, including glomerular hyperfiltration and metabolic dysfunction. This study aimed to characterize the global, regional, and national temporal trends in CKD attributable to BMI from 1990 to 2021 and forecast trends up to 2050.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were obtained from the Global Burden of Disease 2021 Study. Deaths and disability-adjusted life years (DALYs) for patients with CKD attributable to a high BMI were analyzed using age-standardized rates. The estimated annual percentage change was then calculated. Attribution was calculated as the product of the population-attributable fractions (PAFs) related to CKD deaths\/DALYs and disease burden, with deaths\/DALYs as the unit of measurement. Age-period cohort analysis was used to estimate the age, period, and cohort effects. Bayesian age-period-cohort modeling was used to predict the burden of CKD associated with high BMI from 2021 to 2050.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1990 to 2021, the burden of CKD attributable to BMI showed an increasing trend. Age-standardized death and DALY rates increased in all Sociodemographic Index regions from 1990 to 2021. At the national level, most countries have exhibited an increase in burden from 1990 to 2021. Among females, the 85\u201389 age group had the highest number of deaths (28,478), whereas among males, it was the 70\u201374 age group (25,270). Globally, high BMI is a risk factor for CKD, contributing to 27.3% of deaths. With respect to the age effect, deaths from CKD attributable to high BMI increased with age. The burden of CKD attributable to high BMI generally increases from 2021 to 2050.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The burden of CKD attributable to high BMI increased significantly between 1990 and 2021. The growing global burden demands urgent and mechanistically informed health interventions that target the complex pathophysiology of obesity-related kidney diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1612300","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:44:27Z","timestamp":1752126267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Global, regional, and national burdens of chronic kidney disease attributable to high body mass index from 1990 to 2021, with future forecasts up to 2050: a systematic analysis for the global burden of disease study 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Jun","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/jcm12041459","article-title":"Pathogenesis of chronic kidney disease is closely bound up with Alzheimer's disease, especially via the renin-angiotensin system","volume":"12","author":"Ma","year":"2023","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11255-016-1239-6","article-title":"Metabonomic biomarkers for risk factors of chronic kidney disease","volume":"48","author":"Ye","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1501175","DOI":"10.3389\/fmed.2024.1501175","article-title":"Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"11","author":"Guo","year":"2024","journal-title":"Front Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2860143","article-title":"Knowledge and practices towards prevention and early detection of chronic kidney disease and associated factors among hypertensive patients in Gondar town, north West Ethiopia","volume":"2020","author":"Asmelash","year":"2020","journal-title":"Int J Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12902-019-0417-9","article-title":"Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: a retrospective cohort study","volume":"19","author":"Wetmore","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/oby.23145","article-title":"BMI trajectories from childhood to midlife are associated with subclinical kidney damage in midlife","volume":"29","author":"Liu","year":"2021","journal-title":"Obesity"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41574-024-00951-7","article-title":"Obesity and the kidney: mechanistic links and therapeutic advances","volume":"20","author":"Yau","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"111883","DOI":"10.1016\/j.diabres.2024.111883","article-title":"Global health impacts of high BMI: a 30-year analysis of trends and disparities across regions and demographics","volume":"217","author":"Liu","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e064540","DOI":"10.1136\/bmjopen-2022-064540","article-title":"Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the global burden of disease study 2019","volume":"13","author":"Feng","year":"2023","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1212\/WNL.0000000000007861","article-title":"High BMI is associated with low ALS risk: a population-based study","volume":"93","author":"Nakken","year":"2019","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e1003198","DOI":"10.1371\/journal.pmed.1003198","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: an analysis of the global burden of disease study","volume":"17","author":"Dai","year":"2020","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","article-title":"Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study","volume":"54","author":"Zhang","year":"2022","journal-title":"Ann Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e003650","DOI":"10.1136\/rmdopen-2023-003650","article-title":"Time trends in the burden of autoimmune diseases across the BRICS: an age-period-cohort analysis for the GBD 2019","volume":"9","author":"Zhang","year":"2023","journal-title":"RMD Open"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10067-024-06885-9","article-title":"Burden of osteoarthritis in China, 1990-2019: findings from the global burden of disease study 2019","volume":"43","author":"Li","year":"2024","journal-title":"Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/jcm12051828","article-title":"The global burden of Glaucoma: findings from the global burden of disease 2019 study and predictions by Bayesian age-period-cohort analysis","volume":"12","author":"Lin","year":"2023","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/S2468-2667(25)00049-0","article-title":"Time to tackle obesogenic environments","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2022_581","article-title":"Epidemiology of obesity","volume":"274","author":"S\u00f8rensen","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S2213-8587(21)00118-2","article-title":"Health policy and public health implications of obesity in China","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/medicina60101668","article-title":"Exploring adiposity and chronic kidney disease: clinical implications, management strategies, prognostic considerations","volume":"60","author":"Ozbek","year":"2024","journal-title":"Medicina"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"655871","DOI":"10.3389\/fmed.2021.655871","article-title":"A nephrologist perspective on obesity: from kidney injury to clinical management","volume":"8","author":"Garc\u00eda-Carro","year":"2021","journal-title":"Front Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/antiox13121540","article-title":"From adipose to ailing kidneys: the role of lipid metabolism in obesity-related chronic kidney disease","volume":"13","author":"Xu","year":"2024","journal-title":"Antioxidants"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12882-022-03026-9","article-title":"Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease","volume":"23","author":"Bullen","year":"2022","journal-title":"BMC Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/jcm10051065","article-title":"Obesity, abdominal obesity and chronic kidney disease in young adults: a Nationwide population-based cohort study","volume":"10","author":"Bae","year":"2021","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","article-title":"Obesity and prevalent and incident CKD: the hypertension detection and follow-up program","volume":"46","author":"Kramer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","article-title":"Strategies to treat obesity in patients with CKD","volume":"77","author":"Chintam","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fpubh.2020.00360","article-title":"A polish pilot Programme of coordinated care: a herald of change or a missed opportunity? A critical debate","volume":"8","author":"Karasiewicz","year":"2020","journal-title":"Front Public Health"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.kint.2020.05.039","article-title":"Data from the ERA-EDTA registry were examined for trends in excess mortality in European adults on kidney replacement therapy","volume":"98","author":"Boenink","year":"2020","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/ndt\/gfy390","article-title":"How to increase kidney transplant activity throughout Europe-an advocacy review by the European kidney health Alliance","volume":"34","author":"Vanholder","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/ijerph19052649","article-title":"Twenty-year mortality trends in patients with kidney disease in Poland with the use of the years of life lost measure, 2000-2019","volume":"19","author":"Paciej-Go\u0142\u0119biowska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1326418","DOI":"10.3389\/fpubh.2023.1326418","article-title":"Dietary trends and obesity in Saudi Arabia","volume":"11","author":"Alhusseini","year":"2023","journal-title":"Front Public Health"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41390-023-02505-5","article-title":"Media use, dietary intake, and diet quality of adolescents in Saudi Arabia","volume":"94","author":"Mumena","year":"2023","journal-title":"Pediatr Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","article-title":"A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population","volume":"91","author":"Garofalo","year":"2017","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12889-021-11070-7","article-title":"Relationship between BMI with percentage body fat and obesity in Singaporean adults - the Yishun study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/heapro\/dax021","article-title":"Lessons from Singapore's national weight management program, Lose To Win","volume":"33","author":"Vasquez","year":"2018","journal-title":"Health Promot Int"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"966093","DOI":"10.3389\/fpubh.2022.966093","article-title":"The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990-2019: an analysis of the global burden of disease study","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3390\/nu15153433","article-title":"The roles of lipid metabolism in the pathogenesis of chronic diseases in the elderly","volume":"15","author":"Song","year":"2023","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s40520-023-02510-y","article-title":"Epidemiology of chronic kidney disease in older indigenous peoples of Brazil: findings from a cross-sectional survey","volume":"35","author":"Gomes","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jare.2024.02.001","article-title":"The BET inhibitor JQ1 targets fat metabolism and counteracts obesity","volume":"68","author":"Fornelli","year":"2025","journal-title":"J Adv Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrneph.2017.157","article-title":"Immunologic and endocrine functions of adipose tissue: implications for kidney disease","volume":"14","author":"Zhu","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1531811","DOI":"10.3389\/fmed.2025.1531811","article-title":"Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the global burden of disease study 2021","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1612300\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:39:12Z","timestamp":1752154752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1612300\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":43,"alternative-id":["10.3389\/fpubh.2025.1612300"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1612300","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1612300"}}